ing Co. 1970) , between 30 and 40% had objective remissions.
Pre-treatment levels of prolactin were variable, and were not changed by treatment, whether or not remission occurred. Pretreatment levels of oestradiol varied less, but were also substantially unchanged in all patients during treatment. Growth hormone showed no consistent response. In most patients in whom regression of disease was observed, values of luteinizing and follicle stimulating hormone did not vary, but in the majority of non-responders, gonadotrophin levels were lowered. Twenty-four hours after implantation of the TLX-5 lymphoma in CBA mice, the CoA content of liver was significantly reduced (P < 0-001). Significant reductions in the CoA content continued up to the seventh day, when the animals were in a moribund state. The citrate content of liver showed no further significant increases until the seventh day. Significant reductions in energy content (ATP, ADP, AMP) of these livers did not occur until 6 days after implantation.
Control experiments in which normal CBA mice were challenged with i.p. injections of normal CBA spleen cells, or with spleen cells from A strain mice, showed no change in the CoA or citrate content of liver. No decrease in CoA was noted in starvation experiments.
These results indicate that serious metabolic abnormalities occur in the non-involved organs of tumour bearing animals and these may be related to the development of cachexia. Following intravenous injection of 67Ga it is known that there is a concentration of the isotope in several tumours and in a few normal tumours, including lactating mammary gland. Investigations in the lactating bitch have shown that 67Ga and 45Ca were taken up by the mammary tissue at the same rate and that the isotopes reached similar levels in both plasma and milk. The isotopes were found to be associated with calcium binding proteins in milk. It was not possible to show any correlation between 6 7Ga and 45Ca uptake in a transmissible venereal tumour.
UPTAKE
A preliminary study to investigate if there is any association between the " leakiness " of tumour blood vessels as determined by the uptake of 1251-albumin and 67Ga in a melanoma has produced equivocal results.
THE PROGNOSIS FOLLOWING SUR-GICAL EXCISION OF CANINE MAM-MARY CARCINOMATA. D. E. Bos-TOCK, Department of Clinical Veterinary
Medicine, University of Cambridge.
Spontaneously arising canine mammary carcinomata may be of value as models in immunotherapeutic trials for breast cancer in women, but before their full potential can be exploited their behaviour following surgery alone must be known.
For this reason, 227 bitches from which histologically confirmed mammary carcinomata had been excised were followed up.
Only 43% of these animals were eventually destroyed as a result of the original tumour but the accuracy of the prognosis could be improved by histologically sub-dividing the tumours. Papillary and tubular adenocarcinomata carried the most favourable prognosis, the median survival times being 12 and 90 weeks. Dogs with solid carcinomata had a medial post surgical survival time of 44 weeks whereas for those with anaplastic carcinoma it was only 11 weeks. Clinical immunotherapeutic trials will thus be concentrated on dogs with the latter tumour types.
Since most dogs die from their tumour within 12 months of surgery it should be possible to evaluate the effect of post surgical immunotherapy sooner than would be possible with a similar trial in man. The biological behaviour of spontaneous anaplastic or solid carcinoma of the mammary gland in the dog is similar to carcinoma of the breast in women.
AUTORADIOGRAPHY OF EHRLICH
A 14-year old cross-bred terrier bitch developed rapidly growing and infiltrating solid carcinomata in the pelvic mammary glands on both sides. Following euthenasia, metastatic tumours in the lungs were made into a cell suspension and cultured in TC 199 containing 20% FCS. Better growth occurred following transfer to RPMI medium + 30% FCS or a very complex medium containing glutathione, cortisol and insulin. The culture has now reached its 40th passage with an approximate doubling time of 5 days.
Cells from the 30th passage were injected subcutaneously into a Nude mouse and within 22 days palpable tumours appeared. The histological diagnosis was solid carcinoma of similar appearance to the original primary and metastatic tumours in the dog. In previous studies (Franks et al., Nature, Lond., 1973, 243, 91 and Proc. R. Soc. Med. (in press) 1974 ) it has been shown that human tumours can be grown by subcutaneous implantation in immune deficient mice. Growth has been assessed by serial measurements of the vertical and transverse diameters of the palpable tumour, and viability confirmed retrospectively at autopsy.
In this study, a papillary cell carcinoma of the human bladder on its second passage, 117 days after removal from the patient, was subcutaneously implanted in 5 mice. During the 70-day experimental period, needle biopsy was performed under anaesthesia at 14-day intervals using a disposable Menghini biopsy needle. The transverse and vertical diameters of the tumours were also measured using Vernier calipers.
The results show that between Day + 20 and Day + 25 there is a critical period during which the implanted tumours appear to undergo a process of selection, following which there is either an active increase in size or regression. AGGREGATION We have examined cell aggregation in shaking suspensions using a Coulter model Fn counter coupled with a P64 channel analyser. After calibration this apparatus is used to detect the number of cells present in aggregates up to a maximum size of about 50 cells, and thus to calculate the net redistribution of cells between aggregates as aggregation progresses.
